PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Primary Healthcare Service Camp de Tarragona, Institut Catala de la Salut (ICS), Tarragona, Catalunya, Spain.\', \'Unitat de Suport a la recerca Camp de Tarragona-Reus, IDIAP Jordi Gol, Barcelona, Catalunya, Spain.\', \'Primary Healthcare Service Camp de Tarragona, Institut Catala de la Salut (ICS), Tarragona, Catalunya, Spain esatue.tgn.ics@gencat.cat.\', \'Information and Communication Technologies, Institut Catala de la Salut (ICS), Tarragona, Catalunya, Spain.\', \'Department of Microbiology, Hospital Universtari Joan XXIII, Institut Catala de la Salut (ICS), Tarragona, Catalunya, Spain.\', \'Department of Pharmacology, Primary Healthcare Service Camp de Tarragona, Institut Catala de la Salut (ICS), Tarragona, Catalunya, Spain.\', \'Direction, IDIAP Jordi Gol, Barcelona, Catalunya, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1136/bmjopen-2020-041577
?:hasPublicationType
?:journal
  • BMJ open
is ?:pmid of
?:pmid
?:pmid
  • 33303459
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.372
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Influence of prior comorbidities and chronic medications use on the risk of COVID-19 in adults: a population-based cohort study in Tarragona, Spain.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all